NCT05716477View on ClinicalTrials.gov

Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved Patients

CompletedOBSERVATIONAL

Enrollment

146

Participants

Timeline

Start Date

December 23, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions

Colorectal Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

OTHER

Survey Administration

Complete survey

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

Sponsors

Collaborators (1)

Guardant Health, Inc.

All Listed Sponsors

collaborator

Guardant Health, Inc.

INDUSTRY

lead

Ohio State University Comprehensive Cancer Center

OTHER